Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lorena María Rodríguez Ferreira"'
Autor:
M. Barba, Lorena María Rodríguez Ferreira, M. Yagüe, P. Navarro, Begoña Jiménez, J. Rodriguez Pascual, S. Ruiz-Llorente, L. Jimenez, A. Manjunath, Ignacio Jimenez Lopez, A. Barquin, C. Millan, A. Müller, B. Hefel, Z. Dantes, J. Slawska, Juan Francisco Rodriguez-Moreno, J. Garcias-Donas, Elena Sevillano, M. Dorta Suarez
Publikováno v:
Annals of Oncology. 32:S370
Autor:
Caritina Vázquez Triñanes, Alberto Rivera, Milagros Suárez, Lorena María Rodríguez Ferreira, A. Argibay, Rut Lorenzo, Clara Portela, Olalla Lima, B. Gimena, M. Estévez, B. Maure, Julian Fernandez
Publikováno v:
Abstracts Accepted for Publication.
Background Rituximab (RTX) is a drug composed of chimeric monoclonal antibodies against the CD20 protein, producing a depletion of B lymphocytes. Nowadays, it is used to treat severe and refractory systemic autoimmune diseases (SAD). Objectives Analy
Autor:
A. Rivera, M. Estévez, Iria Villaverde Alvarez, Olalla Lima, Milagros Suárez, Lorena María Rodríguez Ferreira, A. Argibay, Caritina Vázquez Triñanes, B. Gimena, B. Maure, Rut Lorenzo Castro
Publikováno v:
Abstracts Accepted for Publication.
Background The most commonly used method for ANA detection is the indirect immunofluorescence test (IFI) on HEp-2 cells. Among ANA, anti-dense fine speckled (DFS) 70 antibodies produce a pattern (nuclear dense fine speckled) that can be confused with